FinTechFunding

Incisive Genetics: Raises $2.5M in Seed Funding

Incisive Genetics Raises $2.5M in Seed Funding

  • Incisive Genetics, a Vancouver BC-based held biotech company, raised $2.5M in seed funding
  • The round was led by investors Noel Hall and Sandra MacPherson of the MacHall group and Haig Farris, OC
  • The company intends to use the funds to develop its manufacturing process and capabilities, advance key studies to enhance its gene editing delivery platform technology
  • Established in 2018 and led by Dr. Blair R. Leavitt, IncisiveGenetics provides a non-viral delivery platform for genetic therapies
  • This delivery platform enables a one-step encapsulation of the active CRISPR components within lipid nanoparticles
  • The company’s pre-clinical pipeline includes programs addressing neurologic and ocular genetic diseases
Previous article
KodyPay: Raises $3.25m
Next article
Nomu Pay: Completes acquisition of first Wirecard APAC entities
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

UK Authorities Tighten Regulations on P2P Crypto Trading

New measures aim to enhance security for crypto traders in the peer-to-peer market. Highlights: UK authorities introduce new regulations...
FinTech

Citi Wealth Strengthens Services with New AI-Powered Team Member

Citi Wealth Management introduces advanced AI technology for enhanced client experience. Highlights: Citi Wealth Management has launched a new...
FinTech

Coinbase Lists First GBP Stablecoin, Expanding Market Options

The new stablecoin aims to enhance trading in the UK market. Highlights: Coinbase has launched the first GBP stablecoin.This...
FinTech

Former Royal Mint Executives Secure Backing for Precious Metals Trading Platform

New platform aims to modernize precious metals trading for investors. Highlights: Former Royal Mint executives launch a new trading...